Biomarker for chemotherapy-resistant blood cancers

    NAME Dr Daniel Speidel
    CANCER TYPE Blood Cancer
    INSTITUTION Children’s Medical Research Institute Westmead
    STATE New South Wales
    GRANT TYPE Other
    PROJECT TYPE Research

    A novel biomarker for chemotherapy-resistant blood cancers that can guide therapy. This projects aims to validate a family of molecules that were recently discovered as biomarker of chemotherapy-resistant blood cancers. Their studies will determine whether the abundance of these molecules in cancer cells can help to choose the most effective therapy.